| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |